Afuco™ Anti-MSLN ADCC Recombinant Antibody (Amatuximab), ADCC Enhanced (CAT#: AFC-TAB-201)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Mesothelin. Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • Spleen lymphocytes from mice fused with OVCAR-3, an ovarian tumorcell line derived from poorly differentiated adenocarcinoma of the ovary.
  • Host Species
  • Chimeric
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Clone
  • Amatuximab
  • Applications
  • IP, IF, FuncS, FC, Neut, ELISA
  • Conjugate
  • Unconjugated
  • Generic Name
  • Amatuximab
  • Related Disease
  • Pancreatic cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Amatuximab; 931402-35-6; MORAb-009; Anti-mesothelin monoclonal antibody MORAb-009; MSLN; mesothelin; CAK1; MPF; CAK1 antigen; megakaryocyte potentiating factor; soluble MPF mesothelin related protein; pre-pro-megakaryocyte-potentiating factor; SMRP;

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Amatuximab"

Anti-Human Mesothelin Recombinant Antibody (Amatuximab)
Recombinant monoclonal antibody to Mesothelin. Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.
DrugMonitor™ Anti-Amatuximab Antibody (VS-1224-YC67)
Amatuximab is a chimeric monoclonal antibody designed for cancer treatment, used in trials for Mesothelioma, Ovarian Cancer, Pancreatic Cancer, and other malignancies. The DrugMonitor™ Anti-Amatuximab Antibody (VS-1224-YC67) is an anti-drug antibody (ADA) against Amatuximab. This drug-based antibody is raised in mice immunized with the Amatuximab. The anti-Amatuximab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Amatuximab in samples.

See other products for "MSLN"

Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibody Products Chimeric Antibody Products Immunotoxin Products Human Antibody Products Chicken IgY Antibody Products Rabbit Monoclonal Antibody Products Fab Antibody Products MHC Tetramer Products for Cancer IgG Antibody Products ScFv Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-201. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare